Category :

Woolpert Welcomes Head of Strategic Growth, Asia-Pacific Susie Henderson

The accomplished global business executive will oversee the firm\'s strategic growth initiatives for the Asia-Pacific region.

EnergyFeb 14, 2025

Alphamab Oncology Announces the First Patient Dosed in a Phase III Clinical Study for Ovarian Cancer of Anti-HER2 Bispecific ADC JSKN003

SUZHOU,China,Feb. 13,2025-- Alphamab Oncology (stock code: 9966.HK) announced that the first patient has been successfully dosed in the Phase III clinical study (Study ID: JSKN003-306) of anti-HER2 bi

ScienceFeb 14, 2025

DAAN Biotherapeutics Signs Antibody Exclusive Licensing Agreement with LigaChem Biosciences for ADC (Antibody-Drug Conjugate) Therapeutic Development

SEOUL,South Korea,Feb. 13,2025-- DAAN Biotherapeutics,a leading innovative drug development company specializing in T-cell receptor (TCR)- based therapies,has signed an exclusive licensing agreement w

Chip TechFeb 14, 2025

Aker Horizons ASA: Fourth-quarter results 2024

FORNEBU,Norway,Feb. 13,2025-- Aker Horizons ASA (OSE:AKH),a developer of green energy and industry,today announced results for the fourth quarter 2024. Aker Horizons\' net capital employed stood at NO

SoftwareFeb 14, 2025

Cloud4C Secures Dual AI Specializations on Microsoft Azure, Strengthening AI Capabilities

SINGAPORE,Feb. 13,2025-- Cloud4C,a global leader in AI-driven cloud and cybersecurity services,has achieved two prestigious AI specializations on Microsoft Azure: \'AI Platform on Microsoft Azure\' an

SpaceFeb 14, 2025

Polyplastics Launches New Eco-friendly PLASTRON (R) ︎LFT with Reduced Weight, Higher Rigidity, and Strong Damping

TOKYO,Feb. 13,2025-- Polyplastics Co.,Ltd.,a global leader in engineering plastics,has launched PLASTRON (R) LFT (long fiber-reinforced thermoplastic) RA627P,an eco-friendly composite of polypropylene

EnergyFeb 14, 2025

Restore Vision Announces First Patient Dosed in Phase I/II Clinical Trial of RV-001 for Gene-Agnostic Retinitis Pigmentosa

The first optogenetic "Chimeric Rhodopsin" gene therapy tested in humans. RV-001 starting dose was generally well tolerated in this open-label trial.

Big DataFeb 14, 2025

Schwab Makes Expanded 24-Hour Trading Available to All Clients

Overnight trading of all S&P 500®,Nasdaq-100® stocks and hundreds of ETFs is now available to all Schwab clients via the thinkorswim® platform suite

Big DataFeb 14, 2025

Webull Masters 2025 Kicks Off: an Exciting Stock Trading Competition in Thailand with Over THB170,000 in Prizes

BANGKOK,Feb. 13,2025-- Webull Securities (Thailand) Co. Ltd. ("Webull Thailand"),the Thai subsidiary of Webull Corporation ("Webull"),a leading global digital investment platform,

AIFeb 14, 2025

Happy Chinese New Year 2025: Jiangsu's Intangible Cultural Heritage Takes the Global Spotlight

NANJING,China,Feb. 13,2025-- On December 4th,2024,UNESCO inscribed the "Spring Festival,Social Practices of the Chinese People in Celebration of Traditional New Year" on its Representative L

SpaceFeb 14, 2025
1 ... 303 304 305 306 307 308 309 ... 1323
Your premier source for cutting-edge news in the realms of technology, artificial intelligence, energy, and more. Explore the future of tech with Arinstar! Stay informed, stay inspired!

Quick Search

Explore our curated content, stay informed about groundbreaking innovations, and journey into the future of science and tech.

© ArinstarTechnology

Privacy Policy